NEW YORK - TelAve -- Lifenome Inc., a pioneer in precision health and longevity in the United States, and Optimo Life, a leader in high-end longevity clinics in Mexico, have joined forces to launch Genetria, a groundbreaking joint venture that will bring cutting-edge precision health solutions in longevity and women's health to Mexico and Latin America.

Genetria will serve as a key player in unlocking the $11 billion precision health market in the region, introducing Lifenome's award-winning Genomics AI-powered predictive health solutions to a rapidly growing market in need of hyper-personalized health interventions. The partnership will integrate Lifenome's advanced biological, physiological, and behavioral data-driven health solutions with Optimo Life's expertise in longevity-focused clinics and preventative health strategies.

More on TelAve News

• Robotphoenix to Jointly Exhibit with DERI SRL at IPACK-IMA 2025 in Milan
• $283.2 Million; $1.40 Per Share in Revenue Reported for 2024 Fueling Impressive 96% Growth for High Tech AI Boosted Marketing Company: iQSTEL $IQST
• Wohler adds two new 12G SDI monitors to their successful range of audio & video monitors, coupled with the launch of four monitors with GPI/O support
• Aquia Nava II LLC Named Prime Awardee on VA's $42.7M Disability Benefits Crew Contract
• Digital Watchdog Collaborates with Allied Telesis to Offer Dedicated Plugin for DW Spectrum

"Genetria represents a major step in making precision health solutions accessible to a broader global audience. By leveraging our AI-powered genomics technology and Optimo Life's expertise in longevity care, we are empowering individuals across Latin America with the tools to optimize their lifespan and healthspan and improve their quality of life," says Ali Mostashari, PhD, CEO of Lifenome Inc.

Optimo Life, along with its sister company Lonvida, has established itself as a leader in high-end longevity clinics in Mexico, offering science-backed solutions to extend healthspan and improve quality of life. With Genetria, Optimo Life will integrate Lifenome's precision health assessments and interventions into its network, allowing individuals to access the most advanced, personalized longevity and women's health solutions available today.

"The future of health lies in precision and personalization. With Genetria, we are bringing the most advanced predictive and preventative health technologies to Latin America, allowing people to take control of their health like never before. We are excited to partner with Lifenome to revolutionize longevity and women's health across the region," says Alfredo Caravajal, CEO of Optimo Life.

More on TelAve News

• Citizens For West Virginia Election Integrity & Election Integrity Network Unite to Advocate for the SAVE Act and Secure U.S. Elections
• Charming Ogawamachi Town, in Saitama Prefecture, Japan, Announces Festivals for 2025
• Meritum Consulting Welcomes New Partners, Poised for Major Growth in 2025 and Beyond
• Sperry Commercial Global Affiliates Expands Investment in Buildout, Bringing Transaction Management to U.S. Affiliates
• Hitachi Construction Machinery Americas Announces New Executive Team

The first product offering of Genetria, called Salud.ia, a precision longevity application powered by DNA and blood testing and wearable data will go live in May in select markets within Mexico. Expansion to other Latin American Countries is slated for 2026-2028.

About LifeNome
LifeNome is a global leader in precision health, offering the world's most advanced Longevity Operating System™ (Longevity OS™) to power personalized health and wellness solutions.

About Optimo Life
Optimo Life, alongside its sister company Lonvida, operates high-end longevity clinics in Mexico, offering science-based preventative health and longevity solutions. The company is at the forefront of personalized medicine, integrating the latest in nutrigenomics, hormone optimization, and cellular therapies to help clients achieve optimal health and extended vitality.